Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Counting to Save Lives: Sanguis Wins 2018 Startup Challenge Perlman Grand Prize with Medical Device for Chemotherapy Patients
  • USA - English


News provided by

The Wharton School

Apr 30, 2018, 14:15 ET

Share this article

Share toX

Share this article

Share toX

Left to right: Daniel Zhang, Divyansh Agarwal, Prateek Agarwal
Left to right: Daniel Zhang, Divyansh Agarwal, Prateek Agarwal

PHILADELPHIA (PRWEB) April 30, 2018 -- Penn Wharton Entrepreneurship is pleased to announce the winner of the second annual Startup Challenge, sponsored by Eric Aroesty, C’92: Sanguis, founded by Divyansh Agarwal, GR’23, M’23, Prateek Agarwal, M’19, and Daniel Zhang, GR’23, M’23. The Showcase took place on April 27 on the University of Pennsylvania campus. Sanguis has developed the world’s first hand-held, portable, and inexpensive blood cell counting device, allowing patients to monitor their health during chemotherapy treatment and detect life-threatening conditions.

Founded by three best friends who met on their first day of medical school at Penn, Sanguis is rooted in making the world a better place and saving lives. The medical device they created measures neutrophil levels—the body’s primary infection fighting cells. When neutrophil counts go down, the body loses its ability to fight infections. With Sanguis, patients can easily test their neutrophil levels at home and contact their doctors right away.

Nearly 15,000 chemotherapy patients die each year from infections and other complications that rush in when the body is unable to defend itself, and Sanguis aims to reduce that number drastically. Prior to winning the Perlman Grand Prize, Sanguis was a member of VIP-Xcelerate, Penn Wharton Entrepreneurship’s three-month accelerator program for the most advanced startups, and recipients of the Penn Wharton Innovation Fund.

Sanguis was chosen at the Startup Showcase, the biggest entrepreneurship event of the year at the University of Pennsylvania, showcasing the best student-founded startups from across the University. Eight Finalist teams in the Startup Challenge were chosen that morning from 27 Semifinalists, after pitching in closed-room sessions to panels of alumni entrepreneurs and investors. The Finalists pitched to a live audience and a panel of judges for over $135,000 in cash and prizes to help them launch their startups.

The Startup Showcase was a triumphant finish to an exciting year of entrepreneurship at Penn and the Wharton School. Students across the University are founding fast-growing companies, and the resources available at Penn and in Philadelphia continue to expand. Penn Wharton Entrepreneurship is proud to be a leader in entrepreneurship education.

In addition to the Finals of the Startup Challenge, the Showcase offered a room full of the best student ventures from across Penn the opportunity to demo their companies for accomplished alumni and interested members of the public. The in-elevator elevator pitches were again a huge favorite, as student entrepreneurs gave short pitches to investors in an actual elevator. Attendees voted for their favorite Showcase venture in the Crowd Favorite Award, and the eight Finalists gave additional short pitches to both a live and virtual audience, competing for the Michelson People’s Choice Award.

The 2018 Startup Challenge winners are:

1. Perlman Grand Prize: $30,000 + $15,000 in legal, accounting, & strategy services to Sanguis
2. Second Prize: $15,000 + $15,000 in legal, accounting, & strategy services to MD Ally
3. Third Prize: $10,000 + $15,000 in legal, accounting, & strategy services to Avisi Technologies
4. Frederick H. Gloeckner Award for Best Undergraduate Team: $10,000 to Avisi Technologies
5. Social Impact Prize: $10,000 to Strella Biotechnology
6. Innovation Award: $10,000 to MD Ally
7. Michelson People’s Choice Award: $3,000 to Strella Biotechnology
8. Crowd Favorite Award: $2,000 to Strella Biotechnology

Previous participants in Wharton’s startup competition include entrepreneurs such as the founders of mission-driven outdoor adventure apparel maker Cotopaxi, innovative startup investment VC firm FundersClub, and pet insurance company PetPlan.

The Startup Challenge Finals judges were:
• Mona Bijoor, C’98, WG’05, Partner, King Circle Capital and Founder, JOOR
• David Cohen, PAR'14, PAR'16, PAR'17, PAR’21, CEO, Chief Investment Officer, and Co-founder, Karlin Asset Management, Inc.
• Carol Curley, WG'81, Chief Investment Officer, The Charian Group and Managing Director, Golden Seeds
• Lucinda Duncalfe, C’85, WG’91, President and CEO, Monetate
• Richard Perlman, W'68, Founder and Executive Chairman, ExamWorks Group, Inc.
• Stephen Tang, WG'92, CEO, OraSure

Startup Challenge & Showcase Sponsors:
• Perlman Grand Prize Sponsor: Ellen Hanson and Richard E. Perlman, W’68
• Platinum Sponsor & Michelson People’s Choice Award Sponsor: Gary and Alya Michelson Foundations
• Sponsor of the Penn Wharton Startup Challenge & Showcase: Eric Aroesty, C’92
• In-kind Sponsors: Blank Rome LLP, Duane Morris LLP, Grant Thornton, KPMG, Morgan Lewis & Bockius LLP

Note on abbreviations:
• W-Wharton undergraduate alum
• C-Penn College of Arts & Sciences alum
• M-Penn Medicine
• GR-Doctorate (ex. GR’23, M’23 indicates Doctor of Science in Medicine expected 2023)
• WG-Wharton MBA alum
• PAR-Penn parent

About Penn Wharton Entrepreneurship
Penn Wharton Entrepreneurship is a resource for students across the University of Pennsylvania who are interested in entrepreneurship and innovation. The program maximizes the ability of students and alumni to address important challenges through entrepreneurship and entrepreneurial thinking. With 24 team members on two coasts, Penn Wharton Entrepreneurship awards over $600,000 to entrepreneurial students every year, engages with over 100 startups each year in the Venture Initiation Program, and offers more than 50 entrepreneurial courses.

About the Wharton School
Founded in 1881 as the first collegiate business school, the Wharton School of the University of Pennsylvania is recognized globally for intellectual leadership and ongoing innovation across every major discipline of business education. With a broad global community and one of the most published business school faculties, Wharton creates economic and social value around the world. The School has 5,000 undergraduate, MBA, executive MBA, and doctoral students; more than 9,000 participants in executive education programs annually and a powerful alumni network of 96,000 graduates.

Emily Hemming, The Wharton School, +1 (215) 898-8036, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.